• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Sanofi Consumer Healthcare India Ltd.
    04 Aug 2025
    4940.50
    0.79%
    Sanofi Consumer Healthcare Q2 - driven by exports, product launches
    Business Line
    Quarter and half-year financials are not directly comparable due to the demerger and voluntary recall of certain variants of key brands, the company said
    Copy LinkShare onShare on Share on Share on
    Promoters have increased holdings from 60.40% to 71.27% in Jun 2025 qtr.
    logo
    Emcure Pharmaceuticals Ltd.
    04 Aug 2025
    1284.20
    -3.14%
    Emcure Pharma shares gain as JM Financial initiates coverage; check target
    Business Standard
    JM Financial initiated coverage on Emcure Pharma with a 'Buy' rating and a target price of 1,740, citing its growth prospects
    Copy LinkShare onShare on Share on Share on
    Emcure Pharmaceuticals Ltd. is trading below its 30 day SMA of 1388.6
    logo
    Dr. Reddy's Laboratories Ltd.
    04 Aug 2025
    1253.10
    -1.73%
    Dr. Reddy's Laboratories Price Target Cut By Citi Over Intensifying Generic Competition Full Details
    Dr. Reddy's Laboratories Price Target Cut By Citi Over Intensifying Generic Competition Full Details
    NDTV Profit
    Citi notes that market expectations for Dr. Reddy's Semaglutide opportunity may be too optimistic.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    logo
    GlaxoSmithKline Pharmaceuticals Ltd.
    01 Aug 2025
    2672.40
    -2.40%
    GSK Pharma on track to bring in its oncology products Jemperli and Zejula
    Business Line
    Bhushan Akshikar, GSK Pharma Managing Director said the company would invest in its innovative portfolio and was on track to launch its oncology assets, Jemperli (dostarlimab) and Zejula (niraparib)
    Copy LinkShare onShare on Share on Share on
    GlaxoSmithKline Phar.. has an average target of 2800.00 from 2 brokers.
    GSK Pharma Q1 results: PAT rises 12% to 279 cr, income declines marginally
    Business Standard | 01 Aug 2025
    logo
    Sun Pharmaceutical Industries Ltd.
    01 Aug 2025
    Tariff Impact 52 week low
    1586.70
    -2.50%
    Broker's call: Sun Pharma (Outperform)
    Business Line
    BNP Paribas
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical Industries Ltd. is trading at high day volume of 7.3M.
    Sun Pharma shares drop nearly 6% after Q1 earnings
    Business Line | 01 Aug 2025 7 more
    Sun Pharma Shares Decline Over 5% As Q1 Profit Falls 20%
    NDTV Profit | 01 Aug 2025
    Sun Pharma Q1 Review Dolat Capital Maintains 'Reduce', Sees Current Valuations To Limit Upside
    NDTV Profit | 01 Aug 2025
    Sun Pharma Q1 net profit falls 20% Y-o-Y; revenue rises 9%
    Business Standard | 31 Jul 2025
    Sun Pharma has no plans to shift manufacturing to US, says management
    Business Line | 31 Jul 2025
    Sun Pharma Q1 results: PAT dips 20% to 2,279 crore; revenue rises 8.6%
    Business Standard | 31 Jul 2025
    Sun Pharmaceutical Q1 Results: Profit Falls 20% As Exceptional Loss Weighs
    NDTV Profit | 31 Jul 2025
    Sun Pharma Q1 Results: Cons profit falls 20% YoY to Rs 2,278 crore, but revenue rises 10%
    Economic Times | 31 Jul 2025
    logo
    J B Chemicals & Pharmaceuticals Ltd.
    01 Aug 2025
    1670.10
    0.04%
    'Buy' JB Chemicals Maintains PL Capital Post Q1 Results Check Target Price
    'Buy' JB Chemicals Maintains PL Capital Post Q1 Results Check Target Price
    NDTV Profit
    JB Chemicals' margins will continue to improve beyond FY27 with grant of perpetual license of acquired opthal portfolio.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 319 to 311 in Jun 2025 qtr
    logo
    Gland Pharma Ltd.
    01 Aug 2025
    1958.10
    -0.75%
    US tariffs call for strategic agility, cost discipline to ensure growth: Gland Pharma Executive Chairman Srinivas Sadu
    Business Line
    Gland Pharma is open to explore strategic M&As to access new technologies, diversify portfolio
    Copy LinkShare onShare on Share on Share on
    Gland Pharma Ltd. is trading above its 200 day SMA of 1706.7
    logo
    Pfizer Ltd.
    01 Aug 2025
    4931.00
    -0.92%
    Trump demands pharma companies slash US prices in blow to industry
    Business Standard
    In the letters, sent to Eli Lilly & Co., Novo Nordisk A/S, Pfizer Inc. and others, Trump insisted companies immediately lower what they charge Medicaid for existing drugs
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. has gained 20.50% in the last 6 Months
    logo
    Pfizer Ltd.
    31 Jul 2025
    4931.00
    -0.92%
    Trump Sets Sept 29 Deadline For J&J, Pfizer, Other Pharma Firms To Lower US Drug Prices
    Trump Sets Sept 29 Deadline For J&J, Pfizer, Other Pharma Firms To Lower US Drug Prices
    NDTV Profit
    Donald Trump, in his letter to big pharma company CEOs, has demanded "most-favored-nation" pricing for Medicaid.
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. is trading below its 30 day SMA of 5239.0
    logo
    Mankind Pharma Ltd.
    31 Jul 2025
    2482.90
    -1.71%
    Mankind Pharma Q1 PAT drops 17.4% despite 24% revenue growth, costs surge
    Business Standard
    Input and finance costs weigh on profitability; chronic, consumer health and BSV acquisition support top line
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 640 to 648 in Jun 2025 qtr.
    Mankind Pharma Q1 results: Profit dips 17% to 445 cr; revenue rises
    Business Standard | 31 Jul 2025 1 more
    Mankind Pharma Q1 Results: Profit Declines 18%, Revenue Up 25%
    NDTV Profit | 31 Jul 2025
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Jinkushal Industries
    • Jain Resource Recycling
    • Gurunanak Agriculture
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd